-
Decoding the spatiotemporal characteristics of ferroptosis: reshaping tumour therapeutic strategie
Author: Song, Lizhou; Shu, Yue; Zhou, Tian; Wang, Yi; Zhang, Haoling; Liao, Yan; Zhu, Chenglong; Zhang, Wangzheqi; Zou, Zui
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00773-5
-
Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meeting (vol 15, 34, 2026
Author: Xue, Bin; Liu, Yifan; Liang, Aibin; Zhang, Wenjun
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00772-6
-
The novel retinoid WYC-209 sensitizes multiple myeloma to carfilzomib via epigenetically upregulating ZMYND
Author: Xu, Jiaxuan; Yan, Jie; Zhang, Haoyu; Dong, Jiahui; Wu, Yue; Qian, Jiajia; Zhao, Quan; Dong, Xiaoqing; Chen, Bing
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00770-8
-
Functional xenogeneic hematopoietic cells maintaining donor-dominant identity and immune tolerance enable therap
Author: Xiong, Shumin; Zhou, Ren; Wei, Chuijin; Wang, Xiaomin; Tang, Yunhan; Dong, Liaoliao; Yu, Ping; Pei, Duanqing; Chen, Zhu; Chen, Sai-Juan; Cheng, Lin
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00767-3
-
Novel non-viral in vivo CAR-T therapies: latest updates from the 2025 ASH annual meetin
Author: Xue, Bin; Liu, Yifan; Liang, Aibin; Zhang, Wenjun
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00765-5
-
Prospects and advances of PROTAC in the treatment of hematologic malignancie
Author: Wang, Xinyang; Zhang, Ming; Mei, Heng
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00759-3
-
Systematic and precise interventions for KRAS-mutant cancer
Author: Liang, Jinghui; Wu, Junxi; Zhang, Yuan; Wang, Hongyu; Zheng, Yiyang; He, Qing
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00763-7
-
Efficacy and safety of ruxolitinib for graft-versus-host disease prophylaxis in patients with aplastic anemia undergoing PBSC-only allogeneic stem cell transplantation: a prospective phase II stud
Author: Zhang, Xiaoyu; Pan, Lulu; Zhao, Yanhong; Ma, Runzhi; Zhang, Lining; Zhang, Ying; Li, Gang; Zhai, Weihua; Ma, Qiaoling; Pang, Aiming; Yang, Donglin; Feng, Sizhou; Zhang, Ping; He, Yi; Qin, Guoyou; Jiang, Erlie; Han, Mingzhe
Journal: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2026; Vol. 15, Issue 1, pp. -. DOI: 10.1186/s40164-026-00753-9
